Identifying mechanisms that shift the balance of HIF transcription factors to suppress HIF1 and enhance EPAS1 may offer therapeutic opportunities to promote vascular repair and reduce atherosclerosis. This evidence concerns the gene EPAS1 and atherosclerosis.